Table 1.
Comparison of paired drugs
| n | Paired couples | TJSI | AJI | RCT |
|---|---|---|---|---|
| 1 | Acyclovir vs doscarnet | + | + | + |
| 2 | Buprenorphine vs alfentanil | + | ||
| 3 | Captopril vs moexipril | + | + | + |
| 4 | Diltiazem vs felodipine | + | + | |
| 5 | Enalapril vs Perindopril | + | + | + |
| 6 | Fluoxetine vs maprotiline | + | + | + |
| 7 | Gemfibrozil vs fenofibrate | + | ||
| 8 | Lovastatin vs fluvastatin | + | + | |
| 9 | Omeprazole vs lansoprazole | + | + | |
| 10 | Zidovudine vs abacavir | + | + | |
| Distinguishability from random chance | 100% | 80% | 40% | |
| 95% Cl | 69%–100% | 44%–98% | 12%–74% | |
Note: Plus indicates when the index for the breakthrough drug was higher than that of the compared drug in a couple.
Abbreviations: Cl, confidence interval; TJSI, Top Journals Selectivity Index; AJI, All Journals Index; RCT, randomized controlled trials.